Some patients with psoriasis who were treated with guselkumab and achieved complete skin clearance experienced a persistent impact on quality of life.

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.

Immunosuppressive therapy may help reduce gastrointestinal (GI) symptoms among patients with systemic sclerosis (SSc), according to study results published in RMD Open.

KONFIDENT phase 3 trial results demonstrated significantly faster symptom relief with sebetralstat compared to placebo.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.